Isuri Rathnayaka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Isuri Rathnayaka has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Afka Deen
Nutritional Biochemistry Program, National Institute of Fundamental Studies
1 shared publication - Dhanushki Wickramarachchi
Nutritional Biochemistry Program, National Institute of Fundamental Studies
1 shared publication - M. A. Wickramasinghe
Laboratory of Nutritional Biochemistry, National Institute of Fundamental Studies, Kandy, Sri Lanka
1 shared publication - Mallique Qader
Institute for Tuberculosis Research, Pharmacognosy Institute, and Department of Pharmaceutical Sciences, Retzky College of Pharmacy, University of Illinois Chicago, Chicago, IL, 60612, United States
1 shared publication - Mostafa E. Rateb
School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley PA1 2BE, UK
1 shared publication - Pathumi Ariyarathna
Nutritional Biochemistry Program, National Institute of Fundamental Studies
1 shared publication
Latest Publications
- Open Access
- 1 April 2026
- Published by Sri Lanka Journals Online in Tropical Agricultural Research
- Vol. 37 (2) , 90-109
Formulation of Cookies Incorporated with Duckweed Powder and Evaluation of Its Physicochemical, Nutritional, Functional, Microbial, and Sensory Properties
Duckweed, a largely underexploited aquatic plant from the family Lemnaceae, is notable for its high protein content, encompassing all essential amino acids, and its abundance of micronutrients. This study explored the feasibility of incorporating duckweed powder into cookie formulations. Based on preliminary investigations, Lemna perpusilla and Spirodela polyrhiza were selected for the production of duckweed powder, which was subsequently assessed for its physicochemical, nutritional, and functional characteristics. Four cookie formulations were then prepared by substituting wheat flour with duckweed powder at levels of 10%, 20%, 30%, and 40%, alongside a control sample composed entirely of wheat flour. Sensory evaluation was performed using a 9-point hedonic test with 40 semi-trained panelists and identified the most preferred cookie, which was further assessed. According to proximate analysis, the selected cookie showed significant differences (p<0.05) from the control, with higher crude protein 12.25±0.02%, crude fat 21.45±0.03%, crude fiber 10.25±0.03%, crude ash 3.76±0.04%, and digestible carbohydrate 47.23±0.10%. The cookie provided 430.98±0.05 kcal/100g, with 22.43±0.04% sugar, 0.74±0.02% salt, and 1.64±0.03% total dietary fiber. Mineral content was significantly higher (p<0.05). Functional properties such as total phenolic content (1.62±0.03 mgGAE/g), flavonoid content (282.05±0.01 mgCAT/g), DPPH radical scavenging activity (212.36±1.20 mM TE/g), and α-amylase inhibition (IC₅₀ 2.26±0.02 (μg/mL) were also high (p<0.05). Microbial levels remained within safe limits for one month, and all chemical and safety standards were met. The findings suggest that duckweed powder can serve as an effective partial replacement for wheat flour, enhancing both the nutritional profile and functional characteristics of cookie formulations.
- 1 April 2026
- Published by Sri Lanka Journals Online in Tropical Agricultural Research
- Vol. 37 (2) , 90-109
Open AccessFormulation of Cookies Incorporated with Duckweed Powder and Evaluation of Its Physicochemical, Nutritional, Functional, Microbial, and Sensory Properties
Duckweed, a largely underexploited aquatic plant from the family Lemnaceae, is notable for its high protein content, encompassing all essential amino acids, and its abundance of micronutrients. This study explored the feasibility of incorporating duckweed powder into cookie formulations. Based on preliminary investigations, Lemna perpusilla and Spirodela polyrhiza were selected for the production of duckweed powder, which was subsequently assessed for its physicochemical, nutritional, and functional characteristics. Four cookie formulations were then prepared by substituting wheat flour with duckweed powder at levels of 10%, 20%, 30%, and 40%, alongside a control sample composed entirely of wheat flour. Sensory evaluation was performed using a 9-point hedonic test with 40 semi-trained panelists and identified the most preferred cookie, which was further assessed. According to proximate analysis, the selected cookie showed significant differences (p<0.05) from the control, with higher crude protein 12.25±0.02%, crude fat 21.45±0.03%, crude fiber 10.25±0.03%, crude ash 3.76±0.04%, and digestible carbohydrate 47.23±0.10%. The cookie provided 430.98±0.05 kcal/100g, with 22.43±0.04% sugar, 0.74±0.02% salt, and 1.64±0.03% total dietary fiber. Mineral content was significantly higher (p<0.05). Functional properties such as total phenolic content (1.62±0.03 mgGAE/g), flavonoid content (282.05±0.01 mgCAT/g), DPPH radical scavenging activity (212.36±1.20 mM TE/g), and α-amylase inhibition (IC₅₀ 2.26±0.02 (μg/mL) were also high (p<0.05). Microbial levels remained within safe limits for one month, and all chemical and safety standards were met. The findings suggest that duckweed powder can serve as an effective partial replacement for wheat flour, enhancing both the nutritional profile and functional characteristics of cookie formulations.
- 22 January 2025
- Published by Taylor & Francis in Natural Product Research
- Vol. 40 (11) , 3134-3142
In vitro anti-diabetic potential of medicinal herbs commonly used in the Ayurvedic system of Sri Lanka with comprehensive metabolite profiling of Phyllanthus emblica using GC-MS and LC-HRMS
This study assessed the in vitro anti-diabetic potential and bioactive constituents of ten Sri Lankan medicinal herbs. Initial screening of aqueous extracts for starch-digesting enzyme inhibition prioritised three plants with notable activity (p ≤ 0.05), for further assessment using methanolic extracts: Phyllanthus emblica (PE), Cassia auriculata (CA), and Hemidesmus indicus (HI). The selected plants were tested for starch-digesting enzyme inhibition, cytotoxicity, and bioactive metabolite identification, with PE subjected to GC-MS and LC-HRMS analyses. All three extracts contained alkaloids, flavonoids, tannins, and terpenoids, except saponins and steroids in PE. GC-MS analysis of PE annotated ten compounds, eight with anti-diabetic properties, while LC-HRMS annotated thirty metabolites, including fourteen anti-diabetic compounds. Cell viability assessments confirmed the non-toxic nature of PE, CA, and HI. The significant enzyme inhibition and non-toxic nature of PE highlight its potential to treat type 2 diabetes. Further in vivo and clinical studies are essential to determining effective dosage and toxicity levels.
- 22 January 2025
- Published by Taylor & Francis in Natural Product Research
- Vol. 40 (11) , 3134-3142
In vitro anti-diabetic potential of medicinal herbs commonly used in the Ayurvedic system of Sri Lanka with comprehensive metabolite profiling of Phyllanthus emblica using GC-MS and LC-HRMS
This study assessed the in vitro anti-diabetic potential and bioactive constituents of ten Sri Lankan medicinal herbs. Initial screening of aqueous extracts for starch-digesting enzyme inhibition prioritised three plants with notable activity (p ≤ 0.05), for further assessment using methanolic extracts: Phyllanthus emblica (PE), Cassia auriculata (CA), and Hemidesmus indicus (HI). The selected plants were tested for starch-digesting enzyme inhibition, cytotoxicity, and bioactive metabolite identification, with PE subjected to GC-MS and LC-HRMS analyses. All three extracts contained alkaloids, flavonoids, tannins, and terpenoids, except saponins and steroids in PE. GC-MS analysis of PE annotated ten compounds, eight with anti-diabetic properties, while LC-HRMS annotated thirty metabolites, including fourteen anti-diabetic compounds. Cell viability assessments confirmed the non-toxic nature of PE, CA, and HI. The significant enzyme inhibition and non-toxic nature of PE highlight its potential to treat type 2 diabetes. Further in vivo and clinical studies are essential to determining effective dosage and toxicity levels.